Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

     1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product

  2.3.2 Market Size By Sample

  2.3.3 Market Size By End Use      

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Product Type & Technology Metrics

4.1.1 Types of POC diagnostic devices – lateral flow assays, biosensors, molecular diagnostics, and immunoassay-based systems

4.1.2 Portable vs handheld vs benchtop POC devices

4.1.3 In-vitro diagnostics (IVD) vs near-patient testing systems

4.1.4 Single-use disposable vs reusable diagnostic platforms

4.1.5 Microfluidics-based POC diagnostic systems

4.1.6 Lab-on-a-chip technology adoption

4.1.7 Multiplex testing and multi-analyte detection systems

4.2 Diagnostic Performance Metrics

4.2.1 Sensitivity and specificity of POC devices

4.2.2 Limit of detection (LOD) across test types

4.2.3 Accuracy compared to central laboratory testing

4.2.4 Time-to-result (TTR) efficiency

4.2.5 False positive and false negative rate analysis

4.2.6 Reproducibility and test consistency

4.2.7 Sample volume requirements and efficiency

4.3 Application & Clinical Use Metrics

4.3.1 Infectious disease testing (COVID-19, influenza, HIV, malaria)

4.3.2 Blood glucose and diabetes monitoring

4.3.3 Cardiac marker testing (troponin, BNP)

4.3.4 Pregnancy and fertility testing

4.3.5 Coagulation and anticoagulation monitoring

4.3.6 Cancer biomarker detection

4.3.7 Chronic disease and metabolic disorder monitoring

4.4 Healthcare Setting Metrics

4.4.1 Hospital-based point-of-care testing adoption

4.4.2 Primary care and clinic deployment

4.4.3 Emergency and critical care usage

4.4.4 Home healthcare and self-testing adoption

4.4.5 Pharmacy-based diagnostic services

4.4.6 Rural and remote healthcare accessibility

4.4.7 Telemedicine integration with POC diagnostics

5. Point-of-Care Diagnostics Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Blood Glucose Monitoring

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Infectious Disease Monitoring

   5.4 Cardiometabolic Disease Testing

   5.5 Hematology Testing

 5.6 Others

6. Point-of-Care Diagnostics Market Segmental Analysis & Forecast, By Sample, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Blood

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Nasal and Oropharyngeal Swabs

    6.4 Urine

   6.5 Others

7. Point-of-Care Diagnostics Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospital Bedside

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Physican’s Office Lab

   7.4 Urgent Care & Retail Clinics

   7.5 Home & Self Testing

8. Point-of-Care Diagnostics Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.2.3 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.2.4 Point-of-Care Diagnostics Market Size & Forecast, By End Use  , 2022–2035

 8.2.5 Point-of-Care Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Point-of-Care Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.3.3 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.3.4 Point-of-Care Diagnostics Market Size & Forecast, By End Use, 2022–2035

 8.3.5 Point-of-Care Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Point-of-Care Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.4.3 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.4.4 Point-of-Care Diagnostics Market Size & Forecast, By End Use, 2022–2035

 8.4.5 Point-of-Care Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Point-of-Care Diagnostics Market Size & Forecast, By Product, 2022–2035

 8.5.3 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.5.4 Point-of-Care Diagnostics Market Size & Forecast, By End Use    , 2022–2035

 8.5.5 Point-of-Care Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Point-of-Care Diagnostics Market Size & Forecast, By Product 2022–2035

 8.6.3 Point-of-Care Diagnostics Market Size & Forecast, By Sample, 2022–2035

 8.6.4 Point-of-Care Diagnostics Market Size & Forecast, By End Use    , 2022–2035

 8.6.5 Point-of-Care Diagnostics Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

9.1 Competitive Developments

  9.1.1 Year-Wise Strategies & Development, 2022–2025

9.6 Key Company Profiles

9.6.1 Abbott Laboratories

 9.6.1.1 Company Overview & Snapshot

 9.6.1.2 Product/Service Portfolio

 9.6.1.3 Key Company Financials

    9.6.1.4 Geographical Presence

    9.6.1.5 SWOT Analysis

9.6.2 F. Hoffmann-La Roche Ltd.

9.6.3 Siemens Healthineers

9.6.4 Danaher Corporation (Cepheid, Radiometer)

9.6.5 Becton Dickinson and Company

9.6.6 Thermo Fisher Scientific

9.6.7 Quidel Corporation (QuidelOrtho)

9.6.8 bioMérieux SA

9.6.9 Chembio Diagnostics

9.6.10 Alere Inc.

9.6.11 Binax

9.6.12 OraSure Technologies

9.6.13 Nova Biomedical

9.6.14 Mindray Medical International

9.6.15 i-STAT

9.6.16 Boehringer Ingelheim

9.6.17 Nihon Kohden Corporation

9.6.18 Sekisui Diagnostics

9.6.19 Polymer Technology Systems

9.6.20 LumiraDx

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures